Prognostic factors in patients with well-differentiated thyroid cancer presenting with pulmonary metastasis

Cancer Biotherapy and Radiopharmaceuticals

Volumn 23, Issue 5, 2008, Pages 655-659

  Showalter, Timothy N ^a   Siegel, Barry A ^b,c   Moley, Jeffrey F ^c,d   Baranski, Thomas J ^c,d   Grigsby, Perry W ^b,c,d  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c USA   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

I 131; Lung; Metastasis; Pulmonary; Thyroid cancer

Indexed keywords

IODINE 131;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CERVICAL LYMPH NODE; CHILD; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; THYROID CANCER; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR DIFFERENTIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IODINE RADIOISOTOPES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; THYROID NEOPLASMS;

EID: 55849116719     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2008.0501     Document Type: Article

References (33)

1. Benbassat CA, Mechlis-Frish S, Hirsch D. Clinicopathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid cancer. World J Surg 2006;30:1088.
2. Hoie J, Stenwig E, Kullmann G, et al. Distant metastases in papillary thyroid cancer. Cancer 1988;61:1.
3. Samuel AM, Rajashekharrao B, Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. J Nucl Med 1998;39:1531.
4. Newman KD, Black T, Heller G, et al. Differentiated thyroid cancer: Determinants of disease progression in patients <21 years of age at diagnosis: A report from the Surgical Discipline Committee of the Children's Cancer Group. Ann Surg 1998;227:533.
5. Collini P, Mattavelli F, Pellegrinelli A, et al. Papillary carcinoma of the thyroid gland of childhood and adolescence: Morphologic subtypes, biologic behavior and prognosis: A clinicopathologic study of 42 sporadic cases treated at a single institution during a 30-year period. Am J Surg Pathol 2006;30:1420.
6. Casara D, Rubello D, Saladini G, et al. Different features of pulmonary metastases in differentiated thyroid cancer: Natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 1993;34:1626.
7. La Quaglia MP, Black T, Holcomb GW, 3rd, et al. Differentiated thyroid cancer: Clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group. J Pediatr Surg 2000;35:955.
8. Clark JR, Lai P, Hall F, et al. Variables predicting distant metastases in thyroid cancer. Laryngoscope 2005;115:661.
9. Jarzab B, Handkiewicz-Junak D, Wloch J. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: A qualitative review. Endocrine Related Cancer 2005;12:773.
10. Schlumberger M, Challeton C, De Vathaire F, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996;37:598.
11. Vassilopoulou-Sellin R, Klein MJ, Smith TH, et al. Pulmonary metastases in children and young adults with differentiated thyroid cancer. Cancer 1993;71:1348.
12. 99mTc-MIBI scans and computed tomography: Results in patients with lung metastases from differentiated thyroid cancer. Nucl Med Commun 2006;27:261.
13. Grigsby PW, Gal-or A, Michalski JM, et al. Childhood and adolescent thyroid carcinoma. Cancer 2002;95:724.
14. Lin JD, Chao TC, Chou SC, et al. Papillary thyroid carcinomas with lung metastases. Thyroid 2004;14:1091.
15. Lin JD, Chao TC, Hsueh C. Follicular thyroid carcinomas with lung metastases: A 23-year retrospective study. Endocr J 2004;51:219.
16. Brink JS, van Heerden JA, McIver B, et al. Papillary thyroid cancer with pulmonary metastases in children: Long-term prognosis. Surgery 2000;128:881.
17. Gow KW, Lensing S, Hill DA, et al. Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: An institutional experience and review of the literature. J Pediatr Surg 2003;38:1574.
18. Spinelli C, Bertocchini A, Antonelli A, et al. Surgical therapy of the thyroid papillary carcinoma in children: Experience with 56 patients < or = 16 years old. J Pediatr Surg 2004;39:1500.
19. Ronga G, Filesi M, Montesano T, et al. Lung metastases from differentiated thyroid carcinoma. A 40 years' experience. Q J Nucl Med Mol Imaging 2004;48:12.
20. Shoup M, Stojadinovic A, Nissan A, et al. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. J Am Coll Surg 2003;197:191.
21. Kaplan EL, Meier P. Nonparametric statistics from incomplete observations. J Am Stat Assoc 1958;53:901.
22. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163.
23. Cox DR. Regression models and life tables. JSTOR 1972;34:187.
24. Haq M, Harmer C. Differentiated thyroid carcinoma with distant metastases at presentation: Prognostic factors and outcome. Clin Endocrinol (Oxf) 2005;63:87.
25. Okada T, Sasaki F, Takahashi H, et al. Management of childhood and adolescent thyroid carcinoma: Long-term follow-up and clinical characteristics. Eur J Pediatr Surg 2006;16:8.
26. Durante C, Haddy N, Baudin E, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 2006;91:2892.
27. Baudin E, Schlumberger M. New therapeutic approaches for metastatic thyroid carcinoma. Lancet Oncol 2007;8:148.
28. Tsang RW, Brierley JD, Simpson WJ, et al. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 1998;82:375.
29. Hindie E, Melliere D, Lange F, et al. Functioning pulmonary metastases of thyroid cancer: Does radioiodine influence the prognosis? Eur J Nucl Med Mol Imaging 2003;30:974.
30. Sisson JC, Giordano TJ, Jamadar DA, et al. 131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma. Cancer 1996;78:2184.
31. Song H, He B, Prideaux A, et al. Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases. J Nucl Med 2006;47:1985.
32. Haq M, Hyer S, Flux G, et al. Differentiated thyroid cancer presenting with thyrotoxicosis due to functioning metastases. Br J Radiol 2007;80:e38.
33. Menzel C, Grunwald F, Schomburg A, et al. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma. J Nucl Med 1996;37:1496.